Envista Q2 sales rise on segments growth
NVST•Outlook
- Envista raised its 2026 core sales growth outlook to 3.5%-4.5% from 2%-4%.
- The company now sees 2026 adjusted EBITDA growth of 11%-14%, up from 7%-13%.
- Envista expects 2026 adjusted diluted EPS of $1.50-$1.55, up from $1.35-$1.45.
Overview
- U.S. dental products maker's Q2 sales rose year over year, beating analyst expectations.
- Adjusted diluted EPS for Q2 rose 58% year over year to $0.41.
- The company raised its full-year outlook for core sales growth, adjusted EBITDA, and adjusted EPS.
Result drivers
- Segment growth - Both reporting segments delivered positive core sales growth, with Equipment & Consumables up 8.5% and Specialty Products & Technologies up 3.1%.
- - Margin expansion was attributed to ongoing contributions from the Envista Business System.
